Orthopediatrics Corp Financials

KIDS Stock  USD 27.16  0.63  2.37%   
Based on the analysis of Orthopediatrics Corp's profitability, liquidity, and operating efficiency, Orthopediatrics Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Orthopediatrics Corp's Current Deferred Revenue is comparatively stable compared to the past year. Accounts Payable is likely to gain to about 15.3 M in 2025, whereas Retained Earnings are likely to drop (186.9 M) in 2025. Key indicators impacting Orthopediatrics Corp's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.02920.0307
Notably Down
Slightly volatile
Current Ratio7.046.25
Moderately Up
Slightly volatile
The financial analysis of Orthopediatrics Corp is a critical element in measuring its lifeblood. Investors should not minimize Orthopediatrics Corp's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(19.82 Million)

  

Orthopediatrics Corp Earnings Geography

Please note, the imprecision that can be found in Orthopediatrics Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orthopediatrics Corp. Check Orthopediatrics Corp's Beneish M Score to see the likelihood of Orthopediatrics Corp's management manipulating its earnings.

Orthopediatrics Corp Stock Summary

Orthopediatrics Corp competes with Orthofix Medical, Sight Sciences, Neuropace, CVRx, and IRhythm Technologies. OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS68752L1008
CUSIP68752L100
LocationIndiana; U.S.A
Business Address2850 Frontier Drive,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.orthopediatrics.com
Phone574 268 6379
CurrencyUSD - US Dollar

Orthopediatrics Corp Key Financial Ratios

Orthopediatrics Corp Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets320.4M304.3M427.7M438.7M504.6M529.8M
Other Current Liab24.9M20.3M19.6M28.9M33.2M34.9M
Net Tangible Assets109.6M100.0M83.3M211.9M243.7M255.9M
Net Debt(27.3M)(6.6M)(8.1M)(21.0M)(18.9M)(19.8M)
Retained Earnings(161.8M)(178.0M)(176.8M)(197.7M)(178.0M)(186.9M)
Accounts Payable10.0M9.3M11.2M12.6M14.5M15.3M
Cash28.8M7.6M9.0M31.1M35.7M28.9M
Long Term Debt1.0M907K763K9.9M8.9M10.3M
Net Receivables17.5M17.9M24.8M34.6M39.8M41.8M
Inventory53.0M57.6M78.2M105.9M121.7M127.8M
Other Current Assets4.0M4.6M5.4M5.7M6.6M6.9M
Total Liab85.6M78.9M49.1M61.7M71.0M50.0M
Short Long Term Debt131K137K144K152K174.8K134.6K
Total Current Assets158.4M133.6M226.7M226.5M260.5M273.5M
Short Term Debt131K137K144K152K174.8K134.6K
Intangible Assets64.2M69.8M79.9M84.6M97.2M102.1M
Capital Surpluse271.2M388.6M394.9M560.8M644.9M677.2M
Good Will70.5M72.3M86.8M83.7M96.3M62.3M

Orthopediatrics Corp Key Income Statement Accounts

The reason investors look at the income statement is to determine what Orthopediatrics Corp's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Expense3.4M2.2M2.4M198K178.2K169.3K
Total Revenue71.1M98.0M122.3M148.7M171.0M179.6M
Gross Profit55.0M73.4M90.7M111.3M127.9M134.3M
Operating Income(20.4M)(17.9M)(21.8M)(25.8M)(23.2M)(22.0M)
Ebit(30.3M)(17.9M)(21.0M)(25.8M)(23.2M)(22.0M)
Research Development5.3M5.5M8.0M10.2M11.7M12.3M
Ebitda(22.3M)(7.2M)(7.9M)(8.4M)(7.5M)(7.9M)
Cost Of Revenue16.0M24.6M31.6M37.5M43.1M45.3M
Income Before Tax(33.7M)(17.4M)(3.7M)(21.3M)(19.2M)(20.1M)
Net Income(32.9M)(16.3M)1.3M(21.0M)(18.9M)(19.8M)
Income Tax Expense(723K)(1.1M)(4.9M)(338K)(304.2K)(289.0K)
Net Interest Income(3.4M)(2.2M)(2.4M)(44K)(50.6K)(53.1K)

Orthopediatrics Corp Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(12.1M)(5.1M)(16.9M)(26.3M)(23.7M)(22.5M)
Change In Cash(41.9M)(21.1M)1.5M22.6M20.3M21.3M
Net Borrowings29.9M(25.1M)(131K)(3.4M)(3.0M)(2.9M)
Free Cash Flow(29.8M)(29.1M)(31.8M)(46.0M)(41.4M)(39.4M)
Depreciation8.0M10.7M13.1M17.4M20.0M21.0M
Other Non Cash Items5.9M354K(20.0M)(623K)(560.7K)(532.7K)
Capital Expenditures11.3M16.0M10.0M19.0M21.8M22.9M
Net Income(32.9M)(16.3M)1.3M(21.0M)(18.9M)(19.8M)
End Period Cash Flow30.1M9.0M10.5M33.0M38.0M29.7M
Change To Netincome2.7M9.0M2.9M(20.7M)(18.6M)(17.7M)
Investments(55M)9.3M(63.3M)528K475.2K499.0K
Change Receivables(5.8M)(451K)(466K)(4.0M)(4.6M)(4.8M)

Orthopediatrics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orthopediatrics Corp's current stock value. Our valuation model uses many indicators to compare Orthopediatrics Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orthopediatrics Corp competition to find correlations between indicators driving Orthopediatrics Corp's intrinsic value. More Info.
Orthopediatrics Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Orthopediatrics Corp's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Orthopediatrics Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Orthopediatrics Corp Systematic Risk

Orthopediatrics Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Orthopediatrics Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Orthopediatrics Corp correlated with the market. If Beta is less than 0 Orthopediatrics Corp generally moves in the opposite direction as compared to the market. If Orthopediatrics Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Orthopediatrics Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Orthopediatrics Corp is generally in the same direction as the market. If Beta > 1 Orthopediatrics Corp moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Orthopediatrics Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Orthopediatrics Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Orthopediatrics Corp growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0258

At this time, Orthopediatrics Corp's Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Orthopediatrics Corp January 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Orthopediatrics Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orthopediatrics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orthopediatrics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Orthopediatrics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orthopediatrics Corp's daily price indicators and compare them against related drivers.

Additional Tools for Orthopediatrics Stock Analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.